These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32975376)

  • 1. Donor-specific HLA antibodies after fresh decellularized vs cryopreserved native allograft implantation.
    Coti I; Wenda S; Andreeva A; Kocher A; Laufer G; Fischer G; Andreas M
    HLA; 2020 Nov; 96(5):580-588. PubMed ID: 32975376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts.
    Hawkins JA; Hillman ND; Lambert LM; Jones J; Di Russo GB; Profaizer T; Fuller TC; Minich LL; Williams RV; Shaddy RE
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):247-52; discussion 252-3. PubMed ID: 12878962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of humoral immune response to donor HLA after implantation of cellularized versus decellularized human heart valve allografts.
    Kneib C; von Glehn CQ; Costa FD; Costa MT; Susin MF
    Tissue Antigens; 2012 Aug; 80(2):165-74. PubMed ID: 22631597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A broad and strong humoral immune response to donor HLA after implantation of cryopreserved human heart valve allografts.
    Welters MJ; Oei FB; Witvliet MD; Vaessen LM; Cromme-Dijkhuis AH; Bogers AJ; Weimar W; Claas FH
    Hum Immunol; 2002 Nov; 63(11):1019-25. PubMed ID: 12392854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation.
    da Costa FD; Dohmen PM; Duarte D; von Glenn C; Lopes SV; Filho HH; da Costa MB; Konertz W
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):572-8. PubMed ID: 15784353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the function and structural integrity of cryopreserved pulmonary homografts versus decellularized pulmonary homografts after 180 days implantation in the juvenile ovine model.
    van den Heever JJ; Jordaan CJ; Lewies A; Bester D; Goedhals J; Botes L; Dohmen PM; Smit FE
    Cell Tissue Bank; 2022 Jun; 23(2):347-366. PubMed ID: 34453660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HLA antibodies after cryopreserved allograft valve implantation does not predict valve dysfunction at three-year follow up.
    Yap CH; Skillington PD; Matalanis G; Davis BB; Tait BD; Hudson F; Ireland L; Nixon I; Yiil M
    J Heart Valve Dis; 2006 Jul; 15(4):540-4. PubMed ID: 16901051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of immune stimulatory cells in fresh and cryopreserved donor aortic and pulmonary valve allografts.
    Oei FB; Stegmann AP; van der Ham F; Zondervan PE; Vaessen LM; Baan CC; Weimar W; Bogers AJ
    J Heart Valve Dis; 2002 May; 11(3):315-24; discussion 325. PubMed ID: 12056721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fresh and cryopreserved arterial homografts: immunological and clinical results.
    Mirelli M; Buzzi M; Pasquinelli G; Tazzari PL; Testi G; Ricchi E; Conte R; Stella A
    Transplant Proc; 2005; 37(6):2688-91. PubMed ID: 16182785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation.
    Smith JD; Ibrahim MW; Newell H; Danskine AJ; Soresi S; Burke MM; Rose ML; Carby M
    J Heart Lung Transplant; 2014 Oct; 33(10):1074-82. PubMed ID: 24954882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of HLA matching and associated factors on aortic valve homograft function.
    Dignan R; O'Brien M; Hogan P; Passage J; Stephens F; Thornton A; Harrocks S
    J Heart Valve Dis; 2000 Jul; 9(4):504-11. PubMed ID: 10947042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts.
    Hoekstra F; Witvliet M; Knoop C; Akkersdijk G; Jutte N; Bogers A; Claas F; Weimar W
    J Heart Lung Transplant; 1997 May; 16(5):570-2. PubMed ID: 9171278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients.
    Hawkins JA; Breinholt JP; Lambert LM; Fuller TC; Profaizer T; McGough EC; Shaddy RE
    J Thorac Cardiovasc Surg; 2000 Feb; 119(2):324-30. PubMed ID: 10649208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
    Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of renal transplant candidates by cryopreserved cadaveric venous or arterial allografts.
    Lopez-Cepero M; Sanders CE; Buggs J; Bowers V
    Transplantation; 2002 Mar; 73(5):817-9. PubMed ID: 11907435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Rejection, Kidney Allograft Function, and Graft Survival in Patients with Circulating Pre-Transplant IgG Antibodies Directed Against Donor HLA-A, -B, or -C Locus Determined Antigens.
    Abuhelaiqa E; Friedlander R; Aull M; Putheti P; Sharma V; Suthanthiran M; Dadhania D
    Clin Transpl; 2016; 32():83-91. PubMed ID: 28564525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients.
    Oei FB; Welters MJ; Knoop CJ; Vaessen LM; Stegmann AP; Weimar W; Bogers AJ
    Eur J Cardiothorac Surg; 2000 Oct; 18(4):466-72. PubMed ID: 11024386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response to human aortic valve homografts.
    Smith JD; Ogino H; Hunt D; Laylor RM; Rose ML; Yacoub MH
    Ann Thorac Surg; 1995 Aug; 60(2 Suppl):S127-30. PubMed ID: 7646143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decellularization reduces calcification while improving both durability and 1-year functional results of pulmonary homograft valves in juvenile sheep.
    Hopkins RA; Jones AL; Wolfinbarger L; Moore MA; Bert AA; Lofland GK
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):907-13, 913e1-4. PubMed ID: 19327516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.